EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies

Niuska Alvarez, Ana Sevilla iD

International Journal of Molecular Sciences · 13.01.2024 · 25 (2) · 1023

DOI: 10.3390/ijms25021023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.01.2024. Verfasst von Niuska Alvarez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms. Die Arbeit wurde bisher 264-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/AEI/10.13039/501100011033 and by the European Union Next Generation EU/PRTR, MCIN/AEI/10.13039/501100011033 and by the ERDF A way of making Europe,, Catalan Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) is a two-stage treatment that implies the use of light energy, oxygen, and light-activated compounds (photosensitizers) to elicit cancerous and precancerous cell death after light activation (phototoxicity). The biophysical, bioengineering aspects and its combinations with other strategies are highlighted in this review, both conceptually and as they are currently applied clinically. We further explore the recent advancements of PDT with the use of nanotechnology, including quantum dots as innovative photosensitizers or energy donors as well as the combination of PDT with radiotherapy and immunotherapy as future promising cancer treatments. Finally, we emphasize the potential significance of organoids as physiologically relevant models for PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNeoplasmsPhotosensitizing AgentsImmunotherapyBioengineeringBiomedical Engineering

Stichwörter der Autor:innen

cancerimmunotherapynanotechnologyphotodynamic therapyphotosensitizerphototoxicityquantum dotsreactive oxygen species (ROS)

Substanzen

Photosensitizing Agents

Autor:innen und Institutionen

  • Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
  • Institute of Biomedicine, University of Barcelona (IBUB), 08036 Barcelona, Spain.

ORCID-Profile: Ana Sevilla

Förderung

  • MCIN/AEI/10.13039/501100011033 and by the European Union Next Generation EU/PRTR
  • MCIN/AEI/10.13039/501100011033 and by the ERDF A way of making Europe,
  • Catalan Government
  • ERDF A way of making Europe
  • European Union Next Generation EU/PRTR

Zitieren

APA

Alvarez, N., & Sevilla, A. (2024). Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies. International Journal of Molecular Sciences, 25(2), 1023. https://doi.org/10.3390/ijms25021023

Vancouver

Alvarez N, Sevilla A. Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies. International Journal of Molecular Sciences. 2024;25(2):1023. doi:10.3390/ijms25021023

BibTeX
@article{Alvarez2024,
  author = {Alvarez, Niuska and Sevilla, Ana},
  title = {Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {2},
  pages = {1023},
  doi = {10.3390/ijms25021023}
}
Kostenlos starten →